Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 202546
Company: BEXIMCO PHARMS USA

Products on ANDA 202546

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
RIBAVIRIN	RIBAVIRIN	200MG	TABLET;ORAL	Discontinued	None	No	No
RIBAVIRIN	RIBAVIRIN	400MG	TABLET;ORAL	Discontinued	None	No	No
RIBAVIRIN	RIBAVIRIN	500MG	TABLET;ORAL	Discontinued	None	No	No
RIBAVIRIN	RIBAVIRIN	600MG	TABLET;ORAL	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 202546

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/12/2014	ORIG-1	Approval				Label is not available on this site.